Examkin

Question

Difficulty: HardOrdering Laboratory Tests

A 27-year-old woman is admitted to the hospital with acute-onset left leg pain and swelling. Compression ultrasonography reveals an acute proximal deep venous thrombosis in the left popliteal and femoral veins. She has no significant past medical history, takes no medications, and has no recent surgeries or periods of immobilization. Her mother experienced a pulmonary embolism at age 40. The patient is immediately started on a therapeutic low-molecular-weight heparin bridge to warfarin. Given the unprovoked nature of the deep venous thrombosis and her family history, an evaluation for inherited thrombophilia is planned by the primary team. Which of the following is the most appropriate approach to ordering laboratory tests for this patient's hypercoagulability evaluation?

  1. Assess Factor V Leiden and Prothrombin G20210A mutations now; measure Antithrombin, Protein C, and Protein S activity levels 2 to 4 weeks after completion of anticoagulation therapy.Answer
  2. B
    Order a comprehensive thrombophilia panel (including genetic testing and natural anticoagulant activity) immediately to establish a baseline prior to the initiation of warfarin.
  3. C
    Defer all thrombophilia laboratory evaluations, including molecular genetic testing, until the patient has completed her initial course of anticoagulation therapy.
  4. D
    Measure Antithrombin, Protein C, and Protein S activity levels now; defer genetic mutation analysis until the acute inflammatory phase of the thrombosis has completely resolved.
  5. E
    Obtain a quantitative D-dimer level now to assess ongoing clot burden; if markedly elevated, proceed with immediate comprehensive hypercoagulability testing.

Answer

The correct approach is to assess for Factor V Leiden and Prothrombin G20210A mutations immediately, but defer measuring Antithrombin, Protein C, and Protein S activity levels until 2 to 4 weeks after all anticoagulation therapy has been completed.
The laboratory evaluation of inherited thrombophilia involves both genetic tests (Factor V Leiden, Prothrombin G20210A) and functional phenotypic assays (Antithrombin, Protein C, Protein S activity). Genetic testing relies on DNA analysis and is not altered by acute thrombosis, systemic inflammation, or anticoagulant use; therefore, these tests can be ordered reliably in the acute inpatient setting. Conversely, acute thrombosis leads to the active consumption of natural anticoagulants, temporarily lowering Antithrombin, Protein C, and Protein S levels. Furthermore, the medical management itself confounds these tests: heparin therapy selectively decreases Antithrombin levels, and warfarin (a vitamin K antagonist) decreases Protein C and Protein S levels. Ordering these functional assays during an acute thrombotic event or while on these specific anticoagulants will yield false-positive results (inappropriately low levels). The correct sequencing is to order the genetic tests immediately to aid in determining the total duration of therapy, but to delay functional assays until 2 to 4 weeks after all anticoagulation has been completed to ensure baseline physiologic levels are accurately measured.

Step-by-Step Solution

1
Identify the clinical indication
The patient has an unprovoked deep venous thrombosis with a significant family history, warranting an inherited thrombophilia evaluation.
Establishing the evidence-based need for laboratory testing is the mandatory first step in diagnostic workup.
2
Differentiate test modalities within the requested panel
Thrombophilia testing consists of DNA-based genetic assays (Factor V, Prothrombin) and plasma-based functional activity assays (Antithrombin, Protein C, Protein S).
Different diagnostic test types are affected differently by acute illness pathophysiology and pharmacologic interventions.
3
Determine optimal test sequencing based on confounding variables
Order genetic tests now as they are unaffected by acute thrombosis. Defer functional assays because acute thrombosis and anticoagulants (heparin, warfarin) cause transient, falsely low levels.
Ensuring proper sequence guarantees that laboratory results accurately reflect the patient's baseline physiology and prevents misdiagnosis.

Key Concept

Optimal timing and sequencing of inherited thrombophilia laboratory testing
Rate this question

Topics

Ordering Laboratory Tests

More questions from this topic